Of the 850,000 cases of sepsis diagnosed annually, as many as 80% start receiving treatment in the emergency department. Early detection and treatment may prevent progression to severe sepsis or septic shock while reducing the number of ICU admissions related to the dangerous bacterial bloodstream infection.

The HemoScreen from PixCell Medical leverages a revolutionary cartridge design that facilitates running a test near the patient providing on-the-spot results. Furthermore, it requires just a few microliters of blood and its operation is fully automatic once the cartridge is inserted into the device. It will rapidly detect disease markers for sepsis in a complete blood (CBC) panel with a 5-part differential.